Which Pharma Companies Have the Most Concentrated General Payments?
A bounded CMS Open Payments analysis of recipient-distribution concentration, with an explicit cohort rule and a direct company-comparison path.
Original data research from PlainPharmaWatch. Every number here is pulled directly from the live database; nothing is hardcoded.
A bounded CMS Open Payments analysis of recipient-distribution concentration, with an explicit cohort rule and a direct company-comparison path.
An identifier-matched PY2023-to-PY2024 comparison showing the largest reported company-level General Payment increases and decreases.
PlainPharmaWatch ranks reporting entities by total payments disclosed to physicians, teaching hospitals, and non-physician practitioners under the federal Sunshine Act.
PlainPharmaWatch catalogues the payment-type categories defined under the Physician Payments Sunshine Act and ranks them by total dollar volume disclosed.
PlainPharmaWatch ranks US states by total dollar volume of payments disclosed under the Sunshine Act, summing across all reporting entities, payment categories, and recipient types.
Figures reflect payments reported by manufacturers under the Physician Payments Sunshine Act; a reported payment documents a financial relationship, not evidence of wrongdoing.
Download the CMS Open Payments company summary extract cited on this page: plainpharmawatch-companies.csv (CC0).